Alida Biosciences
Alida Biosciences is a provider of technology for RNA analysis to improve human health. The company offers new technologies in RNA biology to develop medical treatments and diagnostic assays, operating in the genomics space. The companys platform focuses on epitranscriptomic analysis, enabling researchers to understand RNA modifications and their role in disease mechanisms, which can lead to new therapeutic targets…
Funding snapshot
About
Alida Biosciences is a provider of technology for RNA analysis to improve human health. The company offers new technologies in RNA biology to develop medical treatments and diagnostic assays, operating in the genomics space. The companys platform focuses on epitranscriptomic analysis, enabling researchers to understand RNA modifications and their role in disease mechanisms, which can lead to new therapeutic targets and diagnostic tools. Founded in 2020 and headquartered in San Diego, United States, Alida Biosciences has raised approximately 11.5 million at the Series A stage with 18 employees and investors including Genoa Ventures, FusionX Ventures, Vertical Venture Partners, and HHS.
Business model
Genomics > Applied Genomics > Clinical Genomics > Diagnostics > Sequencing-based > Genetic Diagnosis > Transcriptomics > Coding RNA
Institutional investors
Latest coverage
No articles yet.
Similar startups
Immuneel
Developer of T-cell therapies for the treatment of cancer. It is developing cell therapies by using genetic engineering that modifies healthy immune cells to target cancerous cells.
ImmunoACT
Developer of cell and gene therapies for cancer treatment. It offers a lead product NexCAR19 Talicabtagene autoleucel for B‑cell malignancies such as B‑lymphoma and B‑acute lymphoblastic leukaemia.
HaystackAnalytics
EmbeDL is a provider of an edge AI optimization and deployment platform that streamlines the path from deep learning model development to hardware-ready deployment on embedded systems.
4baseCare
Sitehop is a provider of hardware-enforced network encryption solutions that delivers ultra-low latency, quantum-ready encryption for data-in-motion in critical networks through its SAFE Series product line.